APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Immunoglobulin (IVIg)

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.

Selected research

Market Analysis & Forecast

Global Intravenous Immunoglobulin (IVIg) Market Analysis and Forecast 2026-2032

Report ID 174004270221 December 2025199 pages

Choose your research edition.

Industry ResearchIntravenous Immunoglobulin (IVIg) Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Immunoglobulin (IVIg) Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Intravenous Immunoglobulin (IVIg) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Immunoglobulin (IVIg) Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Immunoglobulin (IVIg) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.

Global Intravenous Immunoglobulin (IVIg) main players are Baxter, Grifols, CSL, Octapharma, etc. Global top four manufacturers hold a share above 65%. North America is the largest market, with a share about 45%.

This report presents an overview of global market for Intravenous Immunoglobulin (IVIg), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Intravenous Immunoglobulin (IVIg), also provides the sales of main regions and countries. Of the upcoming market potential for Intravenous Immunoglobulin (IVIg), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Intravenous Immunoglobulin (IVIg) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Intravenous Immunoglobulin (IVIg) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Intravenous Immunoglobulin (IVIg) sales, projected growth trends, production technology, application and end-user industry.

Intravenous Immunoglobulin (IVIg) Segment by Company

Baxter

Grifols

CSL

Octapharma

Biotest

Kedrion

Hualan Bio

CNBG

Shanghai RAAS

CBPO

LFB Group

BPL

Sichuan Yuanda Shuyang

Intravenous Immunoglobulin (IVIg) Segment by Type

IVIg Liquid

IVIg Powder

Intravenous Immunoglobulin (IVIg) Segment by Application

Immunodeficiency

Autoimmune Disease

Acute Infection

Intravenous Immunoglobulin (IVIg) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Immunoglobulin (IVIg) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Immunoglobulin (IVIg) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Immunoglobulin (IVIg).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Intravenous Immunoglobulin (IVIg) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Intravenous Immunoglobulin (IVIg) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intravenous Immunoglobulin (IVIg) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. IVIg Liquid Major Manufacturers Table 3. IVIg Powder Major Manufacturers Table 4. Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Immunodeficiency Major Manufacturers Table 6. Autoimmune Disease Major Manufacturers Table 7. Acute Infection Major Manufacturers Table 8. Intravenous Immunoglobulin (IVIg) Industry Trends Table 9. Intravenous Immunoglobulin (IVIg) Industry Drivers Table 10. Intravenous Immunoglobulin (IVIg) Industry Opportunities and Challenges Table 11. Intravenous Immunoglobulin (IVIg) Industry Restraints Table 12. Global Intravenous Immunoglobulin (IVIg) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2021-2026) Table 16. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2027-2032) Table 17. Global Intravenous Immunoglobulin (IVIg) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Bottle) Table 18. Global Intravenous Immunoglobulin (IVIg) Sales by Region (2021-2026) & (K Bottle) Table 19. Global Intravenous Immunoglobulin (IVIg) Sales by Region (2027-2032) & (K Bottle) Table 20. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2021-2026) Table 21. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2027-2032) Table 22. Global Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturers (2021-2026) Table 26. Global Intravenous Immunoglobulin (IVIg) Sales Price (USD/Bottle) of Manufacturers (2021-2026) Table 27. Global Intravenous Immunoglobulin (IVIg) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Intravenous Immunoglobulin (IVIg) Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Intravenous Immunoglobulin (IVIg) Manufacturers, Product Type & Application Table 30. Global Intravenous Immunoglobulin (IVIg) Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Intravenous Immunoglobulin (IVIg) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Intravenous Immunoglobulin (IVIg) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2021-2026) Table 37. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2027-2032) Table 38. Global Intravenous Immunoglobulin (IVIg) Sales by Type 2021 VS 2025 VS 2032 (K Bottle) Table 39. Global Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (K Bottle) Table 40. Global Intravenous Immunoglobulin (IVIg) Sales by Type (2027-2032) & (K Bottle) Table 41. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2021-2026) Table 42. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2027-2032) Table 43. Global Intravenous Immunoglobulin (IVIg) Price by Type (2021-2026) & (USD/Bottle) Table 44. Global Intravenous Immunoglobulin (IVIg) Price by Type (2027-2032) & (USD/Bottle) Table 45. Global Intravenous Immunoglobulin (IVIg) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2021-2026) Table 49. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2027-2032) Table 50. Global Intravenous Immunoglobulin (IVIg) Sales by Application 2021 VS 2025 VS 2032 (K Bottle) Table 51. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026) & (K Bottle) Table 52. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2027-2032) & (K Bottle) Table 53. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2021-2026) Table 54. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2027-2032) Table 55. Global Intravenous Immunoglobulin (IVIg) Price by Application (2021-2026) & (USD/Bottle) Table 56. Global Intravenous Immunoglobulin (IVIg) Price by Application (2027-2032) & (USD/Bottle) Table 57. Baxter Company Information Table 58. Baxter Business Overview Table 59. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 60. Baxter Intravenous Immunoglobulin (IVIg) Product Portfolio Table 61. Baxter Recent Development Table 62. Grifols Company Information Table 63. Grifols Business Overview Table 64. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 65. Grifols Intravenous Immunoglobulin (IVIg) Product Portfolio Table 66. Grifols Recent Development Table 67. CSL Company Information Table 68. CSL Business Overview Table 69. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 70. CSL Intravenous Immunoglobulin (IVIg) Product Portfolio Table 71. CSL Recent Development Table 72. Octapharma Company Information Table 73. Octapharma Business Overview Table 74. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 75. Octapharma Intravenous Immunoglobulin (IVIg) Product Portfolio Table 76. Octapharma Recent Development Table 77. Biotest Company Information Table 78. Biotest Business Overview Table 79. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 80. Biotest Intravenous Immunoglobulin (IVIg) Product Portfolio Table 81. Biotest Recent Development Table 82. Kedrion Company Information Table 83. Kedrion Business Overview Table 84. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 85. Kedrion Intravenous Immunoglobulin (IVIg) Product Portfolio Table 86. Kedrion Recent Development Table 87. Hualan Bio Company Information Table 88. Hualan Bio Business Overview Table 89. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 90. Hualan Bio Intravenous Immunoglobulin (IVIg) Product Portfolio Table 91. Hualan Bio Recent Development Table 92. CNBG Company Information Table 93. CNBG Business Overview Table 94. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 95. CNBG Intravenous Immunoglobulin (IVIg) Product Portfolio Table 96. CNBG Recent Development Table 97. Shanghai RAAS Company Information Table 98. Shanghai RAAS Business Overview Table 99. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 100. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Portfolio Table 101. Shanghai RAAS Recent Development Table 102. CBPO Company Information Table 103. CBPO Business Overview Table 104. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 105. CBPO Intravenous Immunoglobulin (IVIg) Product Portfolio Table 106. CBPO Recent Development Table 107. LFB Group Company Information Table 108. LFB Group Business Overview Table 109. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 110. LFB Group Intravenous Immunoglobulin (IVIg) Product Portfolio Table 111. LFB Group Recent Development Table 112. BPL Company Information Table 113. BPL Business Overview Table 114. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 115. BPL Intravenous Immunoglobulin (IVIg) Product Portfolio Table 116. BPL Recent Development Table 117. Sichuan Yuanda Shuyang Company Information Table 118. Sichuan Yuanda Shuyang Business Overview Table 119. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 120. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Portfolio Table 121. Sichuan Yuanda Shuyang Recent Development Table 122. North America Intravenous Immunoglobulin (IVIg) Revenue by Type (2021-2026) & (US$ Million) Table 123. North America Intravenous Immunoglobulin (IVIg) Revenue by Type (2027-2032) & (US$ Million) Table 124. North America Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (K Bottle) Table 125. North America Intravenous Immunoglobulin (IVIg) Sales by Type (2027-2032) & (K Bottle) Table 126. North America Intravenous Immunoglobulin (IVIg) Sales Price by Type (2021-2026) & (USD/Bottle) Table 127. North America Intravenous Immunoglobulin (IVIg) Sales Price by Type (2027-2032) & (USD/Bottle) Table 128. North America Intravenous Immunoglobulin (IVIg) Revenue by Application (2021-2026) & (US$ Million) Table 129. North America Intravenous Immunoglobulin (IVIg) Revenue by Application (2027-2032) & (US$ Million) Table 130. North America Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026) & (K Bottle) Table 131. North America Intravenous Immunoglobulin (IVIg) Sales by Application (2027-2032) & (K Bottle) Table 132. North America Intravenous Immunoglobulin (IVIg) Sales Price by Application (2021-2026) & (USD/Bottle) Table 133. North America Intravenous Immunoglobulin (IVIg) Sales Price by Application (2027-2032) & (USD/Bottle) Table 134. North America Intravenous Immunoglobulin (IVIg) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. North America Intravenous Immunoglobulin (IVIg) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 136. North America Intravenous Immunoglobulin (IVIg) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 137. North America Intravenous Immunoglobulin (IVIg) Sales by Country (2021 VS 2025 VS 2032) & (K Bottle) Table 138. North America Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026) & (K Bottle) Table 139. North America Intravenous Immunoglobulin (IVIg) Sales by Country (2027-2032) & (K Bottle) Table 140. North America Intravenous Immunoglobulin (IVIg) Sales Price by Country (2021-2026) & (USD/Bottle) Table 141. North America Intravenous Immunoglobulin (IVIg) Sales Price by Country (2027-2032) & (USD/Bottle) Table 142. United States Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 143. Canada Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 144. Mexico Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 145. Europe Intravenous Immunoglobulin (IVIg) Revenue by Type (2021-2026) & (US$ Million) Table 146. Europe Intravenous Immunoglobulin (IVIg) Revenue by Type (2027-2032) & (US$ Million) Table 147. Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (K Bottle) Table 148. Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2027-2032) & (K Bottle) Table 149. Europe Intravenous Immunoglobulin (IVIg) Sales Price by Type (2021-2026) & (USD/Bottle) Table 150. Europe Intravenous Immunoglobulin (IVIg) Sales Price by Type (2027-2032) & (USD/Bottle) Table 151. Europe Intravenous Immunoglobulin (IVIg) Revenue by Application (2021-2026) & (US$ Million) Table 152. Europe Intravenous Immunoglobulin (IVIg) Revenue by Application (2027-2032) & (US$ Million) Table 153. Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026) & (K Bottle) Table 154. Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2027-2032) & (K Bottle) Table 155. Europe Intravenous Immunoglobulin (IVIg) Sales Price by Application (2021-2026) & (USD/Bottle) Table 156. Europe Intravenous Immunoglobulin (IVIg) Sales Price by Application (2027-2032) & (USD/Bottle) Table 157. Europe Intravenous Immunoglobulin (IVIg) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Europe Intravenous Immunoglobulin (IVIg) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 159. Europe Intravenous Immunoglobulin (IVIg) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 160. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2021 VS 2025 VS 2032) & (K Bottle) Table 161. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026) & (K Bottle) Table 162. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2027-2032) & (K Bottle) Table 163. Europe Intravenous Immunoglobulin (IVIg) Sales Price by Country (2021-2026) & (USD/Bottle) Table 164. Europe Intravenous Immunoglobulin (IVIg) Sales Price by Country (2027-2032) & (USD/Bottle) Table 165. Germany Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 166. France Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 167. U.K. Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 168. Italy Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 169. Russia Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 170. Spain Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 171. Netherlands Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 172. Switzerland Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 173. Sweden Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 174. Poland Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 175. China Intravenous Immunoglobulin (IVIg) Revenue by Type (2021-2026) & (US$ Million) Table 176. China Intravenous Immunoglobulin (IVIg) Revenue by Type (2027-2032) & (US$ Million) Table 177. China Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (K Bottle) Table 178. China Intravenous Immunoglobulin (IVIg) Sales by Type (2027-2032) & (K Bottle) Table 179. China Intravenous Immunoglobulin (IVIg) Sales Price by Type (2021-2026) & (USD/Bottle) Table 180. China Intravenous Immunoglobulin (IVIg) Sales Price by Type (2027-2032) & (USD/Bottle) Table 181. China Intravenous Immunoglobulin (IVIg) Revenue by Application (2021-2026) & (US$ Million) Table 182. China Intravenous Immunoglobulin (IVIg) Revenue by Application (2027-2032) & (US$ Million) Table 183. China Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026) & (K Bottle) Table 184. China Intravenous Immunoglobulin (IVIg) Sales by Application (2027-2032) & (K Bottle) Table 185. China Intravenous Immunoglobulin (IVIg) Sales Price by Application (2021-2026) & (USD/Bottle) Table 186. China Intravenous Immunoglobulin (IVIg) Sales Price by Application (2027-2032) & (USD/Bottle) Table 187. Asia Intravenous Immunoglobulin (IVIg) Revenue by Type (2021-2026) & (US$ Million) Table 188. Asia Intravenous Immunoglobulin (IVIg) Revenue by Type (2027-2032) & (US$ Million) Table 189. Asia Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (K Bottle) Table 190. Asia Intravenous Immunoglobulin (IVIg) Sales by Type (2027-2032) & (K Bottle) Table 191. Asia Intravenous Immunoglobulin (IVIg) Sales Price by Type (2021-2026) & (USD/Bottle) Table 192. Asia Intravenous Immunoglobulin (IVIg) Sales Price by Type (2027-2032) & (USD/Bottle) Table 193. Asia Intravenous Immunoglobulin (IVIg) Revenue by Application (2021-2026) & (US$ Million) Table 194. Asia Intravenous Immunoglobulin (IVIg) Revenue by Application (2027-2032) & (US$ Million) Table 195. Asia Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026) & (K Bottle) Table 196. Asia Intravenous Immunoglobulin (IVIg) Sales by Application (2027-2032) & (K Bottle) Table 197. Asia Intravenous Immunoglobulin (IVIg) Sales Price by Application (2021-2026) & (USD/Bottle) Table 198. Asia Intravenous Immunoglobulin (IVIg) Sales Price by Application (2027-2032) & (USD/Bottle) Table 199. Asia Intravenous Immunoglobulin (IVIg) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 200. Asia Intravenous Immunoglobulin (IVIg) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 201. Asia Intravenous Immunoglobulin (IVIg) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 202. Asia Intravenous Immunoglobulin (IVIg) Sales by Country (2021 VS 2025 VS 2032) & (K Bottle) Table 203. Asia Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026) & (K Bottle) Table 204. Asia Intravenous Immunoglobulin (IVIg) Sales by Country (2027-2032) & (K Bottle) Table 205. Asia Intravenous Immunoglobulin (IVIg) Sales Price by Country (2021-2026) & (USD/Bottle) Table 206. Asia Intravenous Immunoglobulin (IVIg) Sales Price by Country (2027-2032) & (USD/Bottle) Table 207. Japan Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 208. South Korea Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 209. India Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 210. Australia Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 211. Taiwan Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 212. Southeast Asia Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 213. SAMEA Intravenous Immunoglobulin (IVIg) Revenue by Type (2021-2026) & (US$ Million) Table 214. SAMEA Intravenous Immunoglobulin (IVIg) Revenue by Type (2027-2032) & (US$ Million) Table 215. SAMEA Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2026) & (K Bottle) Table 216. SAMEA Intravenous Immunoglobulin (IVIg) Sales by Type (2027-2032) & (K Bottle) Table 217. SAMEA Intravenous Immunoglobulin (IVIg) Sales Price by Type (2021-2026) & (USD/Bottle) Table 218. SAMEA Intravenous Immunoglobulin (IVIg) Sales Price by Type (2027-2032) & (USD/Bottle) Table 219. SAMEA Intravenous Immunoglobulin (IVIg) Revenue by Application (2021-2026) & (US$ Million) Table 220. SAMEA Intravenous Immunoglobulin (IVIg) Revenue by Application (2027-2032) & (US$ Million) Table 221. SAMEA Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2026) & (K Bottle) Table 222. SAMEA Intravenous Immunoglobulin (IVIg) Sales by Application (2027-2032) & (K Bottle) Table 223. SAMEA Intravenous Immunoglobulin (IVIg) Sales Price by Application (2021-2026) & (USD/Bottle) Table 224. SAMEA Intravenous Immunoglobulin (IVIg) Sales Price by Application (2027-2032) & (USD/Bottle) Table 225. SAMEA Intravenous Immunoglobulin (IVIg) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 226. SAMEA Intravenous Immunoglobulin (IVIg) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 227. SAMEA Intravenous Immunoglobulin (IVIg) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 228. SAMEA Intravenous Immunoglobulin (IVIg) Sales by Country (2021 VS 2025 VS 2032) & (K Bottle) Table 229. SAMEA Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026) & (K Bottle) Table 230. SAMEA Intravenous Immunoglobulin (IVIg) Sales by Country (2027-2032) & (K Bottle) Table 231. SAMEA Intravenous Immunoglobulin (IVIg) Sales Price by Country (2021-2026) & (USD/Bottle) Table 232. SAMEA Intravenous Immunoglobulin (IVIg) Sales Price by Country (2027-2032) & (USD/Bottle) Table 233. Brazil Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 234. Argentina Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 235. Chile Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 236. Colombia Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 237. Peru Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 238. Saudi Arabia Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 239. Israel Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 240. UAE Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 241. Turkey Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 242. Iran Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 243. Egypt Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Table 244. Key Raw Materials Table 245. Raw Materials Key Suppliers Table 246. Intravenous Immunoglobulin (IVIg) Distributors List Table 247. Intravenous Immunoglobulin (IVIg) Customers List Table 248. Research Programs/Design for This Report Table 249. Authors List of This Report Table 250. Secondary Sources Table 251. Primary Sources List of Figures Figure 1. Intravenous Immunoglobulin (IVIg) Image Figure 2. Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous Immunoglobulin (IVIg) Market Size Share 2021 VS 2025 VS 2032 Figure 4. IVIg Liquid Image Figure 5. IVIg Powder Image Figure 6. Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Intravenous Immunoglobulin (IVIg) Market Size Share 2021 VS 2025 VS 2032 Figure 8. Immunodeficiency Image Figure 9. Autoimmune Disease Image Figure 10. Acute Infection Image Figure 11. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Intravenous Immunoglobulin (IVIg) Revenue (2021-2032) & (US$ Million) Figure 13. Global Intravenous Immunoglobulin (IVIg) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2021-2032) Figure 16. Global Intravenous Immunoglobulin (IVIg) Sales (2021-2032) & (K Bottle) Figure 17. Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2021 VS 2025 VS 2032 (K Bottle) Figure 18. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Intravenous Immunoglobulin (IVIg) Sales YoY (2021-2032) & (K Bottle) Figure 20. Europe Intravenous Immunoglobulin (IVIg) Sales YoY (2021-2032) & (K Bottle) Figure 21. China Intravenous Immunoglobulin (IVIg) Sales YoY (2021-2032) & (K Bottle) Figure 22. Asia (Excluding China) Intravenous Immunoglobulin (IVIg) Sales YoY (2021-2032) & (K Bottle) Figure 23. South America, Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales YoY (2021-2032) & (K Bottle) Figure 24. Global Intravenous Immunoglobulin (IVIg) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Intravenous Immunoglobulin (IVIg) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2021-2032) Figure 30. Global Intravenous Immunoglobulin (IVIg) Sales by Type (2021 VS 2025 VS 2032) & (K Bottle) Figure 31. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2021-2032) Figure 33. Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2021-2032) Figure 36. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2021 VS 2025 VS 2032) & (K Bottle) Figure 37. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2021-2032) Figure 39. North America Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2021-2032) Figure 40. North America Intravenous Immunoglobulin (IVIg) Sales Share by Type (2021-2032) Figure 41. North America Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2021-2032) Figure 42. North America Intravenous Immunoglobulin (IVIg) Sales Share by Application (2021-2032) Figure 43. North America Intravenous Immunoglobulin (IVIg) Revenue Share by Country (2021-2032) Figure 44. North America Intravenous Immunoglobulin (IVIg) Sales Share by Country (2021-2032) Figure 45. Europe Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2021-2032) Figure 46. Europe Intravenous Immunoglobulin (IVIg) Sales Share by Type (2021-2032) Figure 47. Europe Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2021-2032) Figure 48. Europe Intravenous Immunoglobulin (IVIg) Sales Share by Application (2021-2032) Figure 49. Europe Intravenous Immunoglobulin (IVIg) Revenue Share by Country (2021-2032) Figure 50. Europe Intravenous Immunoglobulin (IVIg) Sales Share by Country (2021-2032) Figure 51. China Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2021-2032) Figure 52. China Intravenous Immunoglobulin (IVIg) Sales Share by Type (2021-2032) Figure 53. China Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2021-2032) Figure 54. China Intravenous Immunoglobulin (IVIg) Sales Share by Application (2021-2032) Figure 55. Asia Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2021-2032) Figure 56. Asia Intravenous Immunoglobulin (IVIg) Sales Share by Type (2021-2032) Figure 57. Asia Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2021-2032) Figure 58. Asia Intravenous Immunoglobulin (IVIg) Sales Share by Application (2021-2032) Figure 59. Asia Intravenous Immunoglobulin (IVIg) Revenue Share by Country (2021-2032) Figure 60. Asia Intravenous Immunoglobulin (IVIg) Sales Share by Country (2021-2032) Figure 61. SAMEA Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2021-2032) Figure 62. SAMEA Intravenous Immunoglobulin (IVIg) Sales Share by Type (2021-2032) Figure 63. SAMEA Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2021-2032) Figure 64. SAMEA Intravenous Immunoglobulin (IVIg) Sales Share by Application (2021-2032) Figure 65. SAMEA Intravenous Immunoglobulin (IVIg) Revenue Share by Country (2021-2032) Figure 66. SAMEA Intravenous Immunoglobulin (IVIg) Sales Share by Country (2021-2032) Figure 67. Intravenous Immunoglobulin (IVIg) Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Intravenous Immunoglobulin (IVIg) Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • IVIg Liquid
  • IVIg Powder
Applications
  • Immunodeficiency
  • Autoimmune Disease
  • Acute Infection
Companies covered
  • Baxter
  • Grifols
  • CSL
  • Octapharma
  • Biotest
  • Kedrion
  • Hualan Bio
  • CNBG
  • Shanghai RAAS
  • CBPO
  • LFB Group
  • BPL
  • Sichuan Yuanda Shuyang

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Intravenous Immunoglobulin (IVIg) Market by Type
  3. 1.2.1 Global Intravenous Immunoglobulin (IVIg) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 IVIg Liquid
  5. 1.2.3 IVIg Powder
  6. 1.3 Intravenous Immunoglobulin (IVIg) Market by Application
  7. 1.3.1 Global Intravenous Immunoglobulin (IVIg) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Immunodeficiency
  9. 1.3.3 Autoimmune Disease
  10. 1.3.4 Acute Infection
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Intravenous Immunoglobulin (IVIg) Market Dynamics
  1. 2.1 Intravenous Immunoglobulin (IVIg) Industry Trends
  2. 2.2 Intravenous Immunoglobulin (IVIg) Industry Drivers
  3. 2.3 Intravenous Immunoglobulin (IVIg) Industry Opportunities and Challenges
  4. 2.4 Intravenous Immunoglobulin (IVIg) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Intravenous Immunoglobulin (IVIg) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Region
  3. 3.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2021-2026)
  5. 3.2.3 Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2027-2032)
  6. 3.2.4 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Intravenous Immunoglobulin (IVIg) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Intravenous Immunoglobulin (IVIg) Sales by Region
  9. 3.4.1 Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Intravenous Immunoglobulin (IVIg) Sales by Region (2021-2026)
  11. 3.4.3 Global Intravenous Immunoglobulin (IVIg) Sales by Region (2027-2032)
  12. 3.4.4 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers
  2. 4.1.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Intravenous Immunoglobulin (IVIg) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Intravenous Immunoglobulin (IVIg) Sales by Manufacturers
  6. 4.2.1 Global Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Intravenous Immunoglobulin (IVIg) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Intravenous Immunoglobulin (IVIg) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Intravenous Immunoglobulin (IVIg) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Intravenous Immunoglobulin (IVIg) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Intravenous Immunoglobulin (IVIg) Manufacturers, Product Type & Application
  13. 4.7 Global Intravenous Immunoglobulin (IVIg) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Intravenous Immunoglobulin (IVIg) Market CR5 and HHI
  16. 4.8.2 2025 Intravenous Immunoglobulin (IVIg) Tier 1, Tier 2, and Tier 3
5 Intravenous Immunoglobulin (IVIg) Market by Type
  1. 5.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Type
  2. 5.1.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Intravenous Immunoglobulin (IVIg) Sales by Type
  6. 5.2.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2032) & (K Bottle)
  8. 5.2.3 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Intravenous Immunoglobulin (IVIg) Price by Type
6 Intravenous Immunoglobulin (IVIg) Market by Application
  1. 6.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Application
  2. 6.1.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Intravenous Immunoglobulin (IVIg) Sales by Application
  6. 6.2.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2032) & (K Bottle)
  8. 6.2.3 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Intravenous Immunoglobulin (IVIg) Price by Application
7 Company Profiles
  1. 7.1 Baxter
  2. 7.1.1 Baxter Company Information
  3. 7.1.2 Baxter Business Overview
  4. 7.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Baxter Intravenous Immunoglobulin (IVIg) Product Portfolio
  6. 7.1.5 Baxter Recent Developments
  7. 7.2 Grifols
  8. 7.2.1 Grifols Company Information
  9. 7.2.2 Grifols Business Overview
  10. 7.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Grifols Intravenous Immunoglobulin (IVIg) Product Portfolio
  12. 7.2.5 Grifols Recent Developments
  13. 7.3 CSL
  14. 7.3.1 CSL Company Information
  15. 7.3.2 CSL Business Overview
  16. 7.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 CSL Intravenous Immunoglobulin (IVIg) Product Portfolio
  18. 7.3.5 CSL Recent Developments
  19. 7.4 Octapharma
  20. 7.4.1 Octapharma Company Information
  21. 7.4.2 Octapharma Business Overview
  22. 7.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Product Portfolio
  24. 7.4.5 Octapharma Recent Developments
  25. 7.5 Biotest
  26. 7.5.1 Biotest Company Information
  27. 7.5.2 Biotest Business Overview
  28. 7.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Biotest Intravenous Immunoglobulin (IVIg) Product Portfolio
  30. 7.5.5 Biotest Recent Developments
  31. 7.6 Kedrion
  32. 7.6.1 Kedrion Company Information
  33. 7.6.2 Kedrion Business Overview
  34. 7.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Product Portfolio
  36. 7.6.5 Kedrion Recent Developments
  37. 7.7 Hualan Bio
  38. 7.7.1 Hualan Bio Company Information
  39. 7.7.2 Hualan Bio Business Overview
  40. 7.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Portfolio
  42. 7.7.5 Hualan Bio Recent Developments
  43. 7.8 CNBG
  44. 7.8.1 CNBG Company Information
  45. 7.8.2 CNBG Business Overview
  46. 7.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 CNBG Intravenous Immunoglobulin (IVIg) Product Portfolio
  48. 7.8.5 CNBG Recent Developments
  49. 7.9 Shanghai RAAS
  50. 7.9.1 Shanghai RAAS Company Information
  51. 7.9.2 Shanghai RAAS Business Overview
  52. 7.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Portfolio
  54. 7.9.5 Shanghai RAAS Recent Developments
  55. 7.10 CBPO
  56. 7.10.1 CBPO Company Information
  57. 7.10.2 CBPO Business Overview
  58. 7.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 CBPO Intravenous Immunoglobulin (IVIg) Product Portfolio
  60. 7.10.5 CBPO Recent Developments
  61. 7.11 LFB Group
  62. 7.11.1 LFB Group Company Information
  63. 7.11.2 LFB Group Business Overview
  64. 7.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Product Portfolio
  66. 7.11.5 LFB Group Recent Developments
  67. 7.12 BPL
  68. 7.12.1 BPL Company Information
  69. 7.12.2 BPL Business Overview
  70. 7.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 BPL Intravenous Immunoglobulin (IVIg) Product Portfolio
  72. 7.12.5 BPL Recent Developments
  73. 7.13 Sichuan Yuanda Shuyang
  74. 7.13.1 Sichuan Yuanda Shuyang Company Information
  75. 7.13.2 Sichuan Yuanda Shuyang Business Overview
  76. 7.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Portfolio
  78. 7.13.5 Sichuan Yuanda Shuyang Recent Developments
8 North America
  1. 8.1 North America Intravenous Immunoglobulin (IVIg) Market Size by Type
  2. 8.1.1 North America Intravenous Immunoglobulin (IVIg) Revenue by Type (2021-2032)
  3. 8.1.2 North America Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2032)
  4. 8.1.3 North America Intravenous Immunoglobulin (IVIg) Price by Type (2021-2032)
  5. 8.2 North America Intravenous Immunoglobulin (IVIg) Market Size by Application
  6. 8.2.1 North America Intravenous Immunoglobulin (IVIg) Revenue by Application (2021-2032)
  7. 8.2.2 North America Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2032)
  8. 8.2.3 North America Intravenous Immunoglobulin (IVIg) Price by Application (2021-2032)
  9. 8.3 North America Intravenous Immunoglobulin (IVIg) Market Size by Country
  10. 8.3.1 North America Intravenous Immunoglobulin (IVIg) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Intravenous Immunoglobulin (IVIg) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Intravenous Immunoglobulin (IVIg) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Intravenous Immunoglobulin (IVIg) Market Size by Type
  2. 9.1.1 Europe Intravenous Immunoglobulin (IVIg) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2032)
  4. 9.1.3 Europe Intravenous Immunoglobulin (IVIg) Price by Type (2021-2032)
  5. 9.2 Europe Intravenous Immunoglobulin (IVIg) Market Size by Application
  6. 9.2.1 Europe Intravenous Immunoglobulin (IVIg) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2032)
  8. 9.2.3 Europe Intravenous Immunoglobulin (IVIg) Price by Application (2021-2032)
  9. 9.3 Europe Intravenous Immunoglobulin (IVIg) Market Size by Country
  10. 9.3.1 Europe Intravenous Immunoglobulin (IVIg) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Intravenous Immunoglobulin (IVIg) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Intravenous Immunoglobulin (IVIg) Market Size by Type
  2. 10.1.1 China Intravenous Immunoglobulin (IVIg) Revenue by Type (2021-2032)
  3. 10.1.2 China Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2032)
  4. 10.1.3 China Intravenous Immunoglobulin (IVIg) Price by Type (2021-2032)
  5. 10.2 China Intravenous Immunoglobulin (IVIg) Market Size by Application
  6. 10.2.1 China Intravenous Immunoglobulin (IVIg) Revenue by Application (2021-2032)
  7. 10.2.2 China Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2032)
  8. 10.2.3 China Intravenous Immunoglobulin (IVIg) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Intravenous Immunoglobulin (IVIg) Market Size by Type
  2. 11.1.1 Asia Intravenous Immunoglobulin (IVIg) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2032)
  4. 11.1.3 Asia Intravenous Immunoglobulin (IVIg) Price by Type (2021-2032)
  5. 11.2 Asia Intravenous Immunoglobulin (IVIg) Market Size by Application
  6. 11.2.1 Asia Intravenous Immunoglobulin (IVIg) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2032)
  8. 11.2.3 Asia Intravenous Immunoglobulin (IVIg) Price by Application (2021-2032)
  9. 11.3 Asia Intravenous Immunoglobulin (IVIg) Market Size by Country
  10. 11.3.1 Asia Intravenous Immunoglobulin (IVIg) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Intravenous Immunoglobulin (IVIg) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Intravenous Immunoglobulin (IVIg) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Intravenous Immunoglobulin (IVIg) Market Size by Type
  2. 12.1.1 SAMEA Intravenous Immunoglobulin (IVIg) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Intravenous Immunoglobulin (IVIg) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Intravenous Immunoglobulin (IVIg) Price by Type (2021-2032)
  5. 12.2 SAMEA Intravenous Immunoglobulin (IVIg) Market Size by Application
  6. 12.2.1 SAMEA Intravenous Immunoglobulin (IVIg) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Intravenous Immunoglobulin (IVIg) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Intravenous Immunoglobulin (IVIg) Price by Application (2021-2032)
  9. 12.3 SAMEA Intravenous Immunoglobulin (IVIg) Market Size by Country
  10. 12.3.1 SAMEA Intravenous Immunoglobulin (IVIg) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Intravenous Immunoglobulin (IVIg) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Intravenous Immunoglobulin (IVIg) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Intravenous Immunoglobulin (IVIg) Value Chain Analysis
  2. 13.1.1 Intravenous Immunoglobulin (IVIg) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Intravenous Immunoglobulin (IVIg) Production Mode & Process
  6. 13.2 Intravenous Immunoglobulin (IVIg) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Intravenous Immunoglobulin (IVIg) Distributors
  9. 13.2.3 Intravenous Immunoglobulin (IVIg) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst